The expression of the prolactin receptor is under the control of two putative tissue-specific (PI, gonads; PII, liver) and one common (PIII) promoters (Hu, Z. Z., Zhuang, L., and Dufau, M. L. (1996) J. Biol. Chem. 271, 10242-10246). The three promoter regions were co-localized to the rat chromosomal locus 2ql6, in the order 5-PIII-PI-PII-3. To investigate the mechanisms of gonad-specific utilization of PI, the promoter domain, regulatory cis-elements, and trans-factors were identified in gonadal cells. The promoter domain localized to the 152-base pair 5 of the transcriptional start site at ؊549 is highly active in gonadal cells but has minimal activity in hepatoma cells. It contains a steroidogenic factor 1 (SF-1) element (؊668) that binds the SF-1 protein of nuclear extracts from gonadal cells and is essential for promoter activation. A CCAAT box (؊623) contributes minimally to basal activity in the absence of the SF-1 element, and two adjacent TATA-like sequences act as inhibitory elements. Thus, PI belongs to a class of TATAless/non-initiator gene promoters. These findings demonstrate an essential role for SF-1 in transcriptional activation of promoter I of the prolactin receptor gene, which may explain the tissue-specific expression of PI in the gonads but not in the liver and the mammary gland.
The functional diversity of prolactin, involving lactation and reproduction, growth and metabolism, immune regulation, behavior, and homeostasis, has been well documented in the past several decades (2, 3) . However, the mechanisms underlying the regulation of prolactin receptors present in specific target tissues have only recently been investigated. Prolactin receptors are widely expressed, and multiple mRNA transcripts corresponding to the long and short forms of the receptor are present with various proportions in different tissues (4, 5) . The diverse actions of prolactin could be manifested by the expression of different receptor forms and signal transduction pathways and also by differential control of gene transcription and mRNA regulation of PRLR 1 in target tissues.
Recently, the complexity of the mechanism by which the PRLR gene is controlled was revealed by the demonstration of multiple and tissue-specific promoters of the rat prolactin receptor gene (1) . Three putative promoters PI, PII, and PIII that initiate the transcription of alternative first exons E1 1 , E1 2 , and E1 3 , respectively, were identified in the rat gonads and the liver. The three alternate first exons are alternatively spliced to a common noncoding exon 2 that precedes the third exon containing the translation initiation codon of the prolactin receptor. E1 1 is expressed in ovaries and in Leydig cells, E1 2 in the liver, and E1 3 in all three tissues, indicating that PI is gonadspecific, PII is liver-specific, and PIII is a common promoter for the prolactin receptor in these tissues and is the sole promoter utilized in the rat mammary gland (our current study). The various prolactin receptor forms were found not to be dependent on the utilization of individual promoters, which may result from a post-transcriptionally regulated process. However, these accounted for the 5Ј-untranslated region heterogeneity of the first exons of the PRLR mRNA transcripts (E1 1 , E1 2 , and E1 3 ) (1) . The heterogeneity of the 5Ј-untranslated region of the PRLR transcripts was also reported recently in the gonads and the liver by others (6, 7) . Sequence analyses of 5Ј-flanking regions showed a lack of consensus TATA box sequences positioned within the expected distance from the transcriptional start site (TSS) in all three putative promoter regions (1) . However, potentially functional non-canonical TATA box sequences are present in these regions, and in PI two adjacent TATA-like sequences reside 10 and 23 bp 5Ј from the TSS. In addition, consensus sequences for several transcription factors are also present in these promoters, specifically SF-1, C/EBP, and CAAT box in PI; GATA-1, ERE and AP-1 in PII; and GAGA, GATA-1 and AABS in PIII. Therefore, it is assumed that different transcription factors and other cellular and extracellular regulators may be involved in the control and regulation of the PRLR gene in diverse target tissues.
In the present study, we have determined the co-localization and the relative orientation of the three 5Ј-untranslated region/ promoter regions in the rat chromosome, and we have investigated the underlying mechanisms of the tissue-specific promoter control of the PRLR gene in the gonads by the characterization of the gonad-specific promoter domain PI and its relevant cis-elements and trans-factors. These studies have demonstrated that steroidogenic factor-1 (SF-1) (8) , also known as Ad4BP (9) , is an essential transcriptional activator of PI in testicular and ovarian cells. Such regulation by SF-1 appears to determine the specific gonadal utilization of promoter I.
MATERIALS AND METHODS
Animals-Adult male, prepubertal female, and lactating Harlan Sprague Dawley rats (Charles River, Wilmington, MA) were housed in pathogen-free, temperature-and light-controlled conditions (20°C; al-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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ternating light-dark cycle with 14 h of light and 10 h of darkness; lights on at 0600 h). The animals were given free access to tap water and standard Purina lab chow (Ralston-Purina, St. Louis, MO). All animals were killed between 1000 and 1100 h by asphyxiation with CO 2 . All animal studies were approved by the NICHD Animal Care and Use Committee (protocols 94-040 and 94-041). 40-day-old adult male rats were used for preparation of Leydig cells. 24-day-old immature female rats were injected subcutaneously daily for 3 days with 1.5 mg/day 17␤-estradiol (dissolved in propylene glycol) (Sigma). On the 4th day, the animals were sacrificed for preparation of ovarian granulosa cells. The mammary gland of lactating female rats were resected and freed of surrounding adipose tissue and used for mRNA preparation.
Culture of Cell Lines and Primary Rat Gonadal Cells-Cultures of mouse Leydig tumor cells (MLTC-1), a stable steroidogenic cell line that expresses prolactin and luteinizing hormone receptors (kindly provided by Dr. R. V. Rebois, National Institutes of Health, Bethesda, MD), were maintained in RPMI 1640 (BioWhittaker, Walkersville, MD) supplemented with 10% fetal bovine serum and 1 ϫ antibiotic/antimycotic mixture (Life Technologies, Inc.), and the human hepatoma cell line (HepG2, American Type Culture Collection, Rockville, MD), which expresses prolactin receptors, was maintained in minimal essential medium (Life Technologies, Inc.) supplemented with 10% fetal bovine serum, non-essential amino acids, and sodium pyruvate.
Rat ovarian granulosa cells were prepared from estrogen-primed rat ovaries as described previously (10) with some modifications. Briefly, the ovaries were removed and cleared of the surrounding fat tissues. These were washed in Medium 199 (M199, BioWhittaker) containing 0.2% bovine serum albumin and 10 mM HEPES, pH 7.2 (Medium A), and punctured 20 times with a 23-gauge needle in Medium B (Medium A with additional 6.8 mM EGTA) followed by incubation in a CO 2 incubator at 37°C for 10 min and centrifugation at 700 rpm for 10 min. The ovaries were then incubated with Medium C (Medium A with additional 1.8 mM EGTA and 0.5 M sucrose) for 6 min in CO 2 incubator at 37°C and centrifuged as above. To disperse the granulosa cells, the ovaries were pressed against a 40-mesh metal sieve with a spatula, and the dispersed cells were collected. The cells were treated with trypsin (Sigma) (20 mg/ml) for 1 min at 37°C followed by addition of soybean trypsin inhibitor (Sigma) (300 g/ml) and DNase I (Sigma) (100 g/ml) for 4 min at 37°C. The enzymes were removed by centrifugation, and the cells were washed twice with Medium A. Cells were suspended in medium Dulbecco's modified Eagle's medium/F12 (Life Technologies, Inc.) supplemented with 1% fetal bovine serum, and with 15 ng/ml ovine follicle stimulating hormone (ovine FSH-20, National Pituitary Program, NIDDK), 10 ng/ml testosterone (Sigma) and plated at a density of 0.5 ϫ 10 6 cells/cm 2 in 24-well plates and cultured at a CO 2 incubator for 3-5 days.
Rat Leydig cells were prepared from adult male rat testes by collagenase digestion and purified by centrifugal elutriation (11) . The purified Leydig cells were suspended in M199 containing 0.1% bovine serum albumin and 1 ϫ antibiotic/antimycotic and plated at the density of 0.5 ϫ 10 6 cells/cm 2 and cultured for up to 20 h. Fluorescence in Situ Hybridization and Mapping of 5Ј-Flanking/ Promoter Regions-Lambda phage DNA with genomic PRLR DNA inserts of 15 and 14.5 kb were used for fluorescence in situ hybridization analysis. The probes were labeled with biotin (lambda phage clone 11-1, 15 kb, containing PRLR PI/PII regions) or spectrum orange (lambda phage clone 3a, 14.5 kb, containing PIII region) by nick translation (Life Technologies, Inc.) and hybridized to rat metaphase chromosomes as described previously (12) . Briefly, about 200 ng of each probe was used in 10 l of hybridization mixture containing 55% formamide, 2 ϫ SSC, and 1 g of human CotI DNA (Life Technologies, Inc.) that was denatured at 75°C for 5 min. Slides with rat metaphase chromosomal spreads were denatured in 70% formamide, 2 ϫ SSC at 72°C for 2 min, and hybridized with the specified probes at 37°C in a moist chamber overnight. Slides were then washed three times in 50% formamide, 2 ϫ SSC at 45°C for 3 min each. The hybridization signal of the probe was detected by two layers of fluorescein isothiocyanateconjugated avidin (Vector Laboratories, Inc, Burlingame, CA) and amplified with one layer of anti-avidin antibody (Vector). Slides were counterstained with 0.5 g/ml 4,6-diamidino-2-phenylindole in an antifade solution (1 mg/ml p-phenylenediamine dihydrochloride, 10% phosphate-buffered saline (v/v), 90% glycerol (v/v), 4.2% sodium carbonate (w/v)) and was examined with a Zeiss Axiophot microscope equipped with a dual bandpass filter.
For mapping of the plasmid DNA isolated from a P1 genomic library (Genome Systems, Inc., St. Louis, MO) containing the 5Ј-flanking regions of the rat PRLR gene, the plasmid was digested with BamHI or in combination with NotI followed by Southern blot hybridization with oligonucleotide probes derived from E1 1 , E1 2 , and E1 3 .
Construction of Reporter Plasmids and Recombinant Adenovirus Genes-DNA fragments of the 5Ј-flanking region containing promoter I were either generated by restriction enzyme digestion (KpnI/XbaI, Ϫ1566/Ϫ124) or by PCR amplification. For generation of plasmid constructs, the 5Ј-flanking DNA fragments of PI were ligated 5Ј to the luciferase gene (LUC) of the linearized plasmid pGL2 (Promega, Madison, WI). The pGL2 constructs were numbered relative to the translation initiation codon (PI(Ϫ#/Ϫ#)/LUC). The recombinant adenovirus (Adv) luciferase reporter constructs containing the putative promoter region (5Ј-flanking region of the PRLR) 5Ј to the luciferase gene [PI(Ϫ#/ Ϫ#)/LUC/Adv] were prepared as described previously (13) . Briefly, the 5Ј-flanking region of PRLR-luciferase (5ЈPRLR/LUC) minigenes were excised from pGL2 plasmid constructs using SmaI/BamHI and inserted to the EcoRV/BamHI site of pAC plasmid, which contains partial sequences of the adenovirus 5 genome. The resulting pAC/PI/LUC constructs were co-transfected with plasmid pJM17, which contains the remainder of the adenovirus genome into human embryonic 293 cells. In vivo homologous recombination of the plasmids yields recombinant viral genome (PI/LUC/Adv) and subsequent generation of infectious viral particles. Viral plaques were isolated and propagated to a titer of 10 9 ml Ϫ1 in the 293 cells and were used for infection of primary cultures of rat gonadal cells. Structure of the fusion genes was verified by PCR amplification of the insert and the subsequent DNA sequence analysis.
RT-PCR, 5Ј-RACE PCR, and Northern Blot-For RT-PCR analyses of RNA from MLTC, first strand cDNA was synthesized with random primers using Superscript reverse transcriptase (Life Technologies, Inc.) at 42°C for 30 min. Primers used for PCR amplification of exons E1 1 and E1 3 were 5Ј-GTGGCCAGAGCCATGGACAG-3Ј (forward) and 5Ј-AAACTCTTTCCTCGGAGGTCACTAG-3Ј (reverse), 5Ј-TCTCAGA-GACACGCGGCTG-3Ј (forward) and 5Ј-TTCTGCTGGAGAGAAAAG-TCTG-3Ј (reverse), respectively. PCR fragments were resolved on 1.5% agarose gel. 5Ј-RACE PCR analyses of RNA from luciferase reporter plasmid PI(Ϫ1566/Ϫ124)/LUC transfected in MLTC were performed as described previously (1) . First strand cDNA was synthesized using primer GS1 (5Ј-AGCGGTTCCATCCTCTAG-3Ј) (ϩ7 to ϩ24 of the luciferase coding region) and 3Ј-end-tailed with dCTP using terminal deoxynucleotidyltransferase followed by PCR with primer GS2 (5Ј-CTT-TATGTTTTTGGCGTCTTCCA-3Ј) (ϩ44 to ϩ66 of the LUC coding region) and dG-adaptor primer (5Ј-GCGAATTCTCGAGATCTGGGI-IGGGIIGGGIIG-3Ј), where I represents inosine. The PCR products were resolved on 1.5% agarose gel and subjected to Southern blot analyses using nested oligonucleotide probe GS3 (5Ј-TCTACCTAAC-CCGCCCACTGGTT-3Ј) within E1 1 . Primers used for 5Ј-RACE PCR analyses of rat mammary gland PRLR mRNA were same as described previously (1) . Poly(A) ϩ RNAs from the rat ovary, Leydig cells, mammary gland, and MLTC were prepared and analyzed by Northern blot as described previously (1, 4) .
Preparation of Nuclear Proteins-Nuclear proteins from MLTC, rat granulosa cells, and rat Leydig cells were extracted as described (14) with some modifications. Briefly, cells were suspended in buffer A containing 10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl, 0.1 mM EDTA, 0.5 mM DTT, 0.4 mM Pefabloc SC (Boehringer Mannheim), 2 g/ml leupeptin (Sigma), and 2 g/ml pepstatin A (Sigma) with additional 0.3 M sucrose and 2% Nonidet P-40 and homogenized 20 strokes with type B pestle. The nuclei were recovered by centrifugation of the cell homogenate through a 1.5 M sucrose cushion contained in buffer A and lysed in buffer B (10 mM HEPES, pH 7.9, 420 mM KCl, 1.5 mM MgCl, 0.1 mM EDTA, 10% glycerol, 0.5 mM DTT, 0.4 mM pefabloc SC, 2 g/ml leupeptin, and 2 g/ml pepstatin A). The nuclear lysate was dialyzed against buffer D (20 mM HEPES, pH 7.9, 100 mM KCl, 0.1 mM EDTA, 20% glycerol, 0.5 mM DTT, 0.4 mM pefabloc SC, 2 g/ml leupeptin and pepstatin A) overnight at 4°C. The concentration of the nuclear proteins was measured by the protein assay kit (Bio-Rad).
DNase I Footprinting Assay-Double-stranded DNA fragment corresponding to the region of PI at Ϫ827 to Ϫ440 was used for DNase I footprinting analysis. One strand end-labeled DNA probes were generated by first labeling the 5Ј end with [␥-32 P]ATP (3000 mCi/mmol, DuPont NEN) of either forward primer (5Ј-TGTCTGCCTCAT-GAGAATAC-3Ј) or reverse primer (5Ј-TCTACCTAACCCGCCCACTG-GTT-3Ј) followed by PCR amplification of the DNA fragment with one labeled and one unlabeled primer. For each footprinting reaction, 5 ϫ 10 4 cpm of the probe was added to 10 -20 g of nuclear protein in 50 l of mixture containing 20 mM HEPES, pH 7.5, 50 mM KCl, 0.5 mM EDTA, 1 mM DTT, 5% glycerol and incubated at room temperature for 15 min. DNase I digestion was performed by adding 1 ϫ DNase I buffer (25 mM NaCl, 10 mM HEPES, 5 mM MgCl, and 1 mM CaCl 2 ) containing 1 unit of DNase I (Promega) and incubation for 1 min at 22°C. The reaction was terminated by adding 10 l of stop buffer (200 mM NaCl, 30 mM EDTA, 1% SDS, and 100 g/ml yeast RNA) and 110 l of phenol/chloroform. The digested DNA fragments were recovered by ethanol precipitation and resolved on 6% polyacrylamide-urea gel electrophoresis.
Electrophoresis Mobility Shift Assay (EMSA)-Synthesized oligonucleotides were used for gel mobility shift assays unless otherwise indicated. The oligomers were annealed and 5Ј-end-labeled with [␥-32 P]ATP (3000 mCi/mmol, DuPont NEN). 1-3 g of nuclear protein was added to 20 l of reaction containing 12 mM HEPES, pH 7.6, 60 mM KCl, 4 mM Tris-HCl, 5% glycerol, 1 mM EDTA, 1 mM DTT, and 25 g/ml polydeoxyinosinic deoxycytidylic acid on ice for 15-30 min followed by addition of 5 ϫ 10 4 cpm of the probe for additional 15 min. For competition assay, unlabeled DNA sequences were added to the reaction 15 min prior to the addition of the probe. For supershift assay, SF-1 antibody 1 (a gift from Dr. Ken-ichirou Morohashi, Kyushu University, Japan) (15) or antibody 2 (8) (purchased from Upstate Biotechnology, Inc, Lake Placid, NY) was incubated with nuclear proteins for 30 min prior to the addition of the probe. DNA-protein complexes were resolved on 5% native polyacrylamide gel electrophoresis.
Transient Expression of Reporter Genes-MLTC cells were transfected at 50 -70% confluency ϳ48 h after plating using N- [1-(2,3-dioleoyloxy) propyl]-N,N,N-trimethylammonium methylsulfate (Boehringer Mannheim) as described previously (16) . Cells were harvested 40 -60 h after transfection, and whole cell lysates were assayed for luciferase activity (17) . Since the primary rat gonadal cells were not amenable for transient expression of PRLR-PI/LUC reporter gene constructs by conventional liposome-mediated transfection in our experiments, the recombinant adenovirus infection method was applied in this study. Adenovirus reporter gene constructs (PI/LUC/Adv) were added at multiplicity of infection of 100 to the granulosa or Leydig cell culture and incubated for 20 h. Adenovirus construct containing the promoterless luciferase gene served as background control and a construct containing the SV40 promoter-luciferase gene as positive control. The granulosa cells were infected after 3 days of culture, and the infection was allowed to continue for 20 h before termination. The Leydig cells were infected 2 h after plating, and human chorionic gonadotropin was added to a final concentration of 20 ng/ml 6 h before termination. The infection was also allowed to continue for 20 h. Whole cell lysates were used for measurement of luciferase activity.
RESULTS

Chromosomal Localization of PRLR Promoters and Their
Order in the Rat Genome-The fluorescence in situ hybridization method was used to establish the chromosomal location of the rat PRLR gene and to determine whether the three PRLR gene promoter regions that direct transcription of alternative first exons reside at the same gene locus. The genomic probe (15 kb) containing the 5Ј-flanking region corresponding to both PI and PII promoter regions has located these regions at the chromosomal locus 2q16 (Fig. 1, above) . The same finding was obtained using the genomic probe containing coding exons 4 and 5 of the rat PRLR (not shown). The PIII promoter region was also located at the identical locus on the same metaphase chromosome when probed with a genomic fragment (14.5 kb) containing the PIII region (Fig. 1, above) . The order of the three promoters in the gene was determined by mapping overlapping genomic clones (Fig. 1, middle) . The size of the DNA insert cloned from the rat P1 genomic library is ϳ96 kb as determined by restriction digestion and agarose gel electrophoresis (Fig. 1,  middle left) . A 55-kb BamHI fragment was hybridized by two oligomer probes derived from E1 1 (Fig. 1, middle right, lanes  1-3) but not from E1 2 (not shown) or E1 3 (lane 4). Lanes 2 and 3 show a 35-kb positive fragment generated from the 55-kb fragment with NotI digestion, which cleaves at a unique site of the 16-kb vector. Furthermore, a BamHI-digested fragment of 8 kb was specifically hybridized by the oligomer probe derived from E1 3 (lane 4). However, no hybridization of this genomic DNA was revealed by the oligomer probes derived from E1 2 (not shown). These results indicated that this 96-kb genomic fragment of the rat PRLR gene contained both regions corresponding to exons E1 1 and E1 3 as well as their putative promoter regions PI and PIII but not PII and exon E1 2 . Since previously we have established that PI region is located 10 kb 5Ј of PII region (1), we could derive that the order of these 5Ј-flanking/promoter regions of the PRLR gene is 5Ј-PIII-PI-PII-3Ј, which spans over 20 kb in the genome. 1 and E1 3 , in MLTC-Due to the lack of appropriate rat gonadal stable cell lines, we have utilized a mouse Leydig tumor cell line (MLTC-1) (18) for investigation of the transcriptional control of the PRLR gene promoters. For these studies, it was necessary to initially characterize the endogenous expression of PRLR alternative exons in these cells. Northern blot analysis showed a major mRNA transcript of 9.5 kb comparable to the 9.7 kb of the rat species using 5Ј-coding region of the rat PRLR as the probe (Fig. 2A, left) . In addition, minor transcripts of 4.2, 2.4, and 1.4 kb were also revealed in MLTC. Based on the high similarity between the rat and the mouse PRLR cDNAs, primers derived from the rat E1 1 and E1 3 were used for RT-PCR analyses of mRNA from rat ovaries and MLTC cells. PCR products of identical sizes for E1 1 (325 bp) (Fig. 2B, lanes 2-4) and for E1 3 (229 bp) (lanes 5-7) were observed for the rat ovary and MLTC (mouse), indicating analogous expression of alternative first exons E1 1 and E1 3 in both species. Furthermore, recent genomic cloning of the mouse E1 3 and its 5Ј-flanking region showed 94% sequence similarity between the rat and the mouse within the noncoding exon E1 3 and the proximal 5Ј-flanking region (not shown). These results indicate that as in rat gonads, the PRLR expression is also under the control of putative promoters PI and PIII in MLTC cells.
Expression of the Mouse Counterparts of Rat Tissue-specific and Common First Exons, E1
The promoter utilization of the PRLR gene in rat mammary gland was also examined. Northern blot analyses showed that the major mRNA transcript in this tissue is the 1.8-kb species (Fig. 2C, left) , which is also seen in the Leydig cells (right) and the liver (1), and corresponds to the short form of the receptor (1, 4) . 5Ј-RACE PCR analyses of mRNA from the rat mammary gland showed that only E1 3 sequences were present in this tissue by sequencing the PCR products (not shown) and by Southern blot analysis of the PCR products (Fig. 2D) . Neither E1 1 nor E1 2 sequences were found to be present in the mammary tissue by Southern hybridization by oligonucleotide probes derived from E1 1 (lane 3 and 4) or E1 2 (lane 5 and 6). This result indicated that PIII is the sole promoter utilized in the rat mammary gland and further demonstrated that the usage of PI is restricted to the gonads among the tissues examined.
Transcriptional Activity of Promoter I in MLTC Cells-A luciferase reporter gene construct containing the 5Ј-flanking region with adjacent E1 1 sequence [PI(Ϫ1566/Ϫ124)/LUC] was examined for its promoter activity in the steroidogenic MLTC and the non-steroidogenic cell line HepG2. This genomic fragment exhibited strong promoter activity, which was 43-fold over that of the promoterless vector and about 60% that of the SV40 promoter in MLTC. In contrast, only minimal induction was observed in HepG2 cells, where the SV40 promoter displayed activities comparable to those observed in MLTC cells (Fig. 3, left) . This finding indicated the specificity of activation Right, 5Ј-RACE PCR analysis of reporter gene mRNA transcripts from PI(Ϫ1566/Ϫ124)/LUC transfected in MLTC. The two gene-specific primers (GS1 and GS2) used were derived from regions of the luciferase gene to avoid interference from the endogenous mouse PRLR mRNA. Specific extended products of ϳ540 bp were generated from both total RNA (lane 1) and poly(A ϩ ) RNA (lane 2). The scheme for the analysis is indicated below the Southern blot. The sequences for GS1 and GS2 were 5Ј-AGCGGTTCCATCCTCTAG-3Ј and 5Ј-CTTTATGTTTTTGGCGTCT-TCCA-3Ј located at ϩ24 and ϩ66 of the luciferase coding region, respectively. The wavy line is a portion of the polylinker sequence from the vector (55 bp). CC in the lower right indicates dC-tailing of the first strand cDNA synthesized with GS1. The sequence of dG adaptor primer is 5Ј-GCGAATTCTCGAGATCTGGGIIGGGIIGGGIIG-3Ј. The calculated size from the reporter construct is 538 bp. 5) . DNA standards are shown in lanes 1 and 8. Primers were derived from E1 1 and E1 3 as indicated below the gel. The primers used were 5Ј-GTGGCCAGAGCCATGGACAG-3Ј (upper strand) and 5Ј-AAACTC-TTTCCTCGGAGGTCACTAG-3Ј (lower strand) for E1 1 , 5Ј-TCTCAG-AGACACGCGGCTG-3Ј (upper strand) and 5Ј-TTCTGCTGGAGAG-AAAAGTCTG-3Ј (lower strand) for E1 3 . The expected band size is indicated by the arrow in base pairs (bp). C, Northern blot analyses of PRLR mRNA from rat mammary gland (left) and Leydig cells (right). The probe used was the same as in A. The 1.8 kb is the major species in mammary tissue, whereas the 9.7 and 1.8 kb are the major species in rat Leydig cells (1) . D, 5Ј-RACE PCR analyses of PRLR mRNA from the rat mammary gland. Primers at different locations were selected to generate different sizes of PCR products. PCR products of identical sizes as from those of the rat gonads and liver were obtained and hybridized by oligomer probes derived from E1 3 (lanes 1 and 2) but not from E1 1 (lanes 3 and 4) or E1 2 (lanes 5 and 6) .
FIG. 2. Endogenous expression of mouse counterparts of the rat PRLR exons E1
of promoter I in MLTC and is consistent with the pattern of promoter utilization in vivo, where PI activity was found only in gonads but not in the liver (1) and the mammary gland (Fig.  2D) . The transcription initiation site from the PI(Ϫ1566/Ϫ124)/ LUC construct transfected in MLTC was determined by the 5Ј-RACE PCR method. An extended product of ϳ540 bp was revealed on Southern hybridization of the PCR products by a nested probe (GS3, Fig. 3, right, above) , and the transcriptional initiation site derived from this experiment was consistent with that reported for the rat ovary (Ϫ549 relative to translation initiation codon at ϩ1) (1) (Fig. 3, right, below) . These results indicate that MLTC is an appropriate cell line for characterization of the regulatory components of this gonad-specific promoter (PI), since the PI/LUC construct is highly active and faithfully transcribed in MLTC.
Localization of Promoter Domain of PI by Deletion Analysis and Identification of Cis-element(s) and Specific Nuclear Protein Binding to the Promoter Region of PI in MLTC-
The PRLR PI/LUC constructs with serial deletion of the 5Ј-flanking region were expressed in MLTC to localize the minimal promoter domain. Deletion of the 5Ј-flanking sequences beyond Ϫ700 had no significant effect on luciferase activity (Fig. 4) . The region between Ϫ700 and Ϫ549 was required for promoter activity, whereas deletion of the downstream exon 1 sequences (Ϫ124 to Ϫ549) had no significant effect on promoter activity. Thus, the 152-bp region between Ϫ700 and Ϫ549 retained full promoter activity in transfected MLTC cells. In contrast, the PI(Ϫ1566/Ϫ124)/LUC construct (Fig. 3) and the deletion mutants of PI including the minimal promoter domain Ϫ700/Ϫ549 (not shown) exerted only minor promoter activities in HepG2 cells, further indicating the tissue specificity of promoter I for expression in gonadal cells. The regulatory cis-elements and transcriptional activators required for this promoter were further analyzed by the DNA-protein binding analyses and sitedirected mutagenesis of regulatory elements within the promoter domain.
DNase I footprinting analysis using nuclear extracts from MLTC was employed to examine the specific nuclear protein binding activities within the promoter domain. DNA probes corresponding to the region of Ϫ440 to Ϫ827 labeled at 5Ј ends of either upper or lower strands were used in the DNase I footprinting assay (Fig. 5) . Regions at Ϫ679 to Ϫ661 and Ϫ681 to Ϫ663 were protected for upper (Fig. 5, lanes 3-5) and lower strands (lanes 13-15) , respectively, indicating a single footprint with asymmetrical binding of the protein complex to the double helixes of this region (Fig. 5, middle) . Within this footprint resides the consensus binding element for the steroidogenic factor 1 CCAAGGTCA. Preincubation with unlabeled DNA se- , lanes 2 and 12) as control. The probes were also incubated with nuclear proteins in the presence of unlabeled DNA competitors as indicated (lanes 6 -10 and 16 -20) . The molecular ladders are from sequencing reactions using primers derived from the labeled ends of either probes (see "Materials and Methods"). The protected region on either strand was indicated by shaded boxes. The sequences protected on both strands and their positions in relation to the transcription initiation site (Ϫ549) are indicated (between gels). quences containing the SF-1 element (see also Fig. 6 ) can effectively prevent formation of the footprint (Fig. 5, lanes 6, 7,  16, and 17) , whereas the mutated SF-1 sequence (m1, see also Fig. 6 ) had no effect (lanes 8 and 18) . Although the region Ϫ628/Ϫ648 downstream of the putative SF-1 element contains a consensus C/EBP binding site (TTGTGTAA), sequences containing either wild type (lanes 9 and 19) or mutation of the C/EBP binding site (lanes 10 and 20) did not affect the footprinting pattern, indicating that the nuclear protein complex binds specifically to a single region containing the SF-1 element.
Electrophoretic mobility shift assay of MLTC nuclear extract using oligonucleotide probes (probes A and B, Fig. 6 ) containing the footprint sequence showed a major protein complex (Fig. 6,  lanes 1, 10, and 15 ) that was specifically competed by unlabeled wild-type sequence even at a molar excess of 10 ( lanes 2-4, 16 , and 17) and was either supershifted (lanes 12 and 22) or inhibited (lanes 13, 14, and 23 ) by specific SF-1 polyclonal antibodies but not by normal rabbit serum (NRS, lanes 11 and 21) . Mutation of the SF -1 element (m1, m2, and m3, Fig. 6, lanes 5-7,  18 -20, and below) did not compete for the SF-1 protein binding, indicating that CCAAGGTCA (Ϫ676 to Ϫ668) is required for the SF-1 binding, conforming to the sequence requirement for SF-1 in other genes (19) . It was noted that a sequence (AACAG-GCCA, Ϫ682 to Ϫ674) resembling the SF-1 consensus sequence is overlapping (underlined) at 5Ј with the SF-1 binding site (in bold) (CGAAACAGGCCAAGGTCAAAC). To more accurately define the SF-1 binding site, the adjacent nucleotides were mutated and the DNA binding activity was evaluated. When the upstream AGG (Ϫ677) was mutated to cta (Fig. 6, m4) , or cat, or tta (not shown), the SF1 binding was completely competed (Fig. 6, lane 8) by unlabeled mutant sequences. Furthermore, mutation of nucleotides AAC at Ϫ665 (m5) and at further upstream sites (Ϫ680, not shown) to ctg also competed for the binding, indicating that these flanking nucleotides are not required for SF-1 binding activity. These results demonstrate that the SF-1 binding site resides at CCAAGGTCA (Ϫ676/ Ϫ668) but not at AACAGGCCA (Ϫ682/Ϫ674). Moreover, the longer probe B (62 bp) containing the consensus sequence for C/EBP (TTGTGTAA) in addition to the SF-1 element (Fig. 6 , lower right) was shown to bind to the same protein complex(es) as the shorter probe A (30 bp) lacking the C/EBP sequence (lanes 15-23) . This DNA-protein complex was not competed by the sequence Ϫ648/Ϫ628 (lane 24), further indicating that the consensus C/EBP site did not have significant binding activity at the given condition (Fig. 6 ). These findings are consistent with those derived from footprinting analysis that revealed a single protected region corresponding to the SF-1 element.
The trans-factors for promoter I present in the nuclei of the rat gonadal cells were also evaluated using EMSA. A single protein complex from granulosa cell nuclear extracts was shown to bind CCAAGGTCA (Fig. 7, lanes 1-10) as was found in MLTC cells. The retarded band was supershifted (lane 12) or inhibited (lane 14) by SF-1 antibodies but not by normal rabbit serum (lane 11). Similar results were obtained with rat Leydig cell nuclear protein extracts (lanes 15-23) . However, the SF-1 binding complex was resolved as a doublet, and these bands may represent different states of the SF-1 protein.
Transcriptional Activation of Promoter I by SF-1 in MLTC and in Rat Gonadal Cells-Mutation of the SF-1 binding site not only abolished the SF-1 protein binding activity (Figs. 6 and 7) but also markedly decreased the promoter activity (by 8-fold) in MLTC (Fig. 8, construct 2) . Similarly, deletion of SF-1 element between Ϫ660 and Ϫ700 decreased the promoter activity by 10-fold (construct 5). This indicates a crucial role for SF-1 in the transcriptional activation of promoter I in MLTC. A further reduction to basic level in promoter activity was observed when the deletion was extended to the position Ϫ627 , below) were used for the EMSA. Probe A contains the consensus SF-1 element (underlined sequences shown below) and probe B (DNA fragment generated by PCR) contains additional consensus sequence for C/EBP element (TTGTGTAA). Wild-type and mutated sequences of the probe were shown below. Probes were incubated with the nuclear protein in the absence (lanes 1, 10, and  15) or presence of excess molar of unlabeled DNA competitors, wild-type DNA (lanes 2-4, 16, 17, and 24) , or mutated DNA (lanes 5-9 and 18 -20) , or in the presence of normal rabbit serum (NRS, lanes 11 and 21) or SF-1 antibodies (Ab1, lanes 12 and 22; Ab2, lanes 13, 14, and 23) . The specific DNA-protein complex (SF-1) and free probes are indicated by arrows. SF-1 is defined as the protein from ovarian granulosa and Leydig cells that is responsible for DNA-specific retardation of the designated band.
(construct 6), which disrupted the consensus CCAAT box sequences (CCAATTA, Ϫ629/Ϫ623), suggesting that a sequence element downstream of Ϫ660 may also contribute to the basal promoter activity. Mutation of the CCAAT box caused a small but significant reduction (30%) in promoter activity (Fig. 8,  construct 3) . However, the activity attributable to the CCAAT element was only 10% in the absence of SF-1 sequence (mutation or deletion). Therefore, the CCAAT box element may participate minimally in the basal transcriptional activation of PI. In contrast, mutation of the two adjacent TATA-like sequences positioned at 10 and 23 bp 5Ј from the transcriptional initiation site caused marked activation of promoter I (by 113%).
The promoter domain Ϫ700/Ϫ549 was also evaluated for its transcriptional activation in primary cultures of rat granulosa cells and Leydig cells using recombinant adenovirus-reporter gene infection method. In granulosa cells, the wild-type PI promoter domain (Ϫ700/Ϫ549) showed 7.6-fold induction of luciferase activity over that of the promoterless adenovirusreporter gene construct (Basic) (Fig. 9, left) , an induction that is about 28% that observed for the control SV40 promoter (SV40). Mutation of the SF-1 element reduced the activity to 25% wild type (SF1X), indicating that this factor is also a major transcriptional activator of this promoter in the granulosa cells. In rat Leydig cell, PI promoter domain caused a significant induction (5.9-fold) over the basic construct, and the SF-1 mutated construct displayed reduced promoter activity to 33% wild type (Fig. 9, right) but significantly higher than that of the basic. Thus, the findings in the Leydig cells are consistent with those observed in MLTC and the rat granulosa cells.
DISCUSSION
Previous studies have identified three putative PRLR gene promoters (PI, PII, and PIII) that are alternatively utilized in a tissue-specific manner and suggested that the expression of PRLR in different tissues may be subject to differential regulation by different regulators at various levels (1) . In this study, we have demonstrated that the three alternative promoters are co-localized in the rat chromosome 2q16 in the order of 5Ј-PIII-PI-PII-3Ј, indicating that multiple PRLR mRNA species are transcribed from the same PRLR gene through usage of alternative promoters.
Our current study has predominantly focused on the elucidation of the mechanism controlling the gonad-specific expression of E1 1 by promoter I. The mouse Leydig tumor cell line (MLTC) has been used for characterization of cis-elements and transcription factor(s) required for promoter I activity. Analyses of endogenous PRLR mRNA transcripts in MLTC indicated that the mouse gonadal cell line expresses the counterparts of the rat first exons E1 1 and E1 3 and therefore possess promoters I and III activities. The expression of the PI(Ϫ1564/Ϫ124)/LUC construct in MLTC and HepG2 cells has not only demonstrated faithful transcription initiation from this transfected construct but also revealed preferential activation of PI in MLTC. This is in agreement with the in vivo expression pattern (1) , where PI is utilized in the rat gonads but not in the rat liver.
From deletion analyses, we have identified a 152-bp region (Ϫ700 to Ϫ549) as the minimal promoter I domain of the PRLR gene (Fig. 4) , whereas sequences upstream of Ϫ700 do not influence the transcriptional activation of this promoter in transfected MLTC cells. We demonstrated that steroidogenic factor-1 binds with high affinity to the sequence CCAAGGTCA (Ϫ676/Ϫ668) positioned 119 bp upstream of the transcription initiation site, which is essential for the activity of this promoter in MLTC cultures as well as in primary cultures of rat ovarian granulosa and Leydig cells. The position of the SF-1 element in this promoter domain is consistent with its location in SF-1-dependent steroidogenic P450 genes (9, 19) . SF-1 is a zinc finger DNA binding protein and is a member of the orphan nuclear receptor superfamily (9, 20) . SF-1 was first identified as a transcriptional activator for steroidogenic P450 genes (9, 19) and subsequently was found to be important for a number of other genes including inhibin, mü llerian inhibiting substance, oxytocin, and gonadotropin ␣ and ␤ subunits (21) (22) (23) (24) (25) . The targeted disruption of the Ftz/F1 gene in the mouse has demonstrated that SF-1 is not only essential for steroidogenesis but is also crucial for gonadal and adrenal development and sexual differentiation (8) . The absence of an SF-1 binding element in the promoter region of PII and PIII (1) may explain the lack of expression of the liver-specific promoter II in the gonads and suggests that a different transcriptional mechanism is involved in the activation of promoter PIII. Conversely, SF-1 protein is not expressed in the liver or mammary gland, which may explain the lack of PI activity in both tissues. In contrast, hepatocyte nuclear factor 4, an abundant transcription factor in the liver, has been reported to be a transcriptional activator of the promoter II that is functional in the liver (6) . In our study, only PIII but neither PI nor PII activities was found in the rat mammary gland as revealed by Northern blot and 5Ј-RACE PCR analyses of mRNA transcripts, consistent with the notion that PI and PII are utilized specifically in the gonads and liver, respectively.
To our knowledge, this is the first report of a receptor gene that requires SF-1 as the major transcriptional activator and for the tissue-specific utilization of its alternative promoters. Although the gonadotropin releasing hormone receptor gene was recently shown to require a functional SF-1 element for its specific expression in ␣T3-1 cells, mutation of an upstream element in the presence of the downstream SF-1 element caused 63% reduction in promoter activity, indicating that SF-1 is not a major transactivator but a co-activator of the gonadotropin releasing hormone receptor gene promoter (26) . Although the rat luteinizing hormone receptor gene contains an SF-1 consensus sequence located 5Ј adjacent to its promoter domain, it was not found to be functional in the rat. 2 Furthermore, different mechanisms are involved in the promoter activation of all other pituitary hormone receptors cloned to date. Therefore, the gene for the PRLR can be viewed as one of a class of genes regulated by SF-1, unique among those of the receptors for pituitary trophic hormones. This may imply important functional correlation between PRLR and other SF-1 regulated gonadal-specific genes in the regulation of reproductive functions.
Additional factors may be required for full activation of this promoter, since mutation or deletion of SF-1 motif (Ϫ676/Ϫ668) greatly (70 -90%) but not completely abolished the promoter activity. Although our current study using DNA-protein binding analyses has not identified the existence of an additional nuclear protein binding site within the promoter region that may contribute to the basal promoter activity, this could not be ruled out. It is probable that the presence of low affinity or unstable nuclear protein binding may not be readily detected by these approaches. Among other potential functional elements present within this promoter, the consensus C/EBP element (Ϫ643/Ϫ636) did not bind to C/EBP or participate in the activation of the PI promoter (not shown). The CCAAT element and the two adjacent TATA-like sequences present within this promoter located 75 and 10 base pairs, respectively, from the TSS, appeared to affect the basal promoter activation (Fig. 8) . The disruption of the CCAAT box sequence caused a minor reduction (30%) in the promoter activity. However, in the absence of a functional SF-1 element (mutation or deletion), the region containing the CCAAT box showed only ϳ10% of the wild-type activity. This activity was comparable to that observed in HepG2 cells transfected with PI(Ϫ1566/Ϫ124)/LUC. However, the minimal activity presumably induced by the CCAAT element in transfected HepG2 cells was not effective for transcriptional activation in vivo since expression of the exon E1 1 was not observed in liver or mammary gland. The pentanucleotide CCAAT sequence is commonly found 60 -80 bp upstream of the TSS (27) . A number of nuclear proteins that can specifically bind to the CCAAT element have been identified, including human CCAAT-binding proteins CP1, CP2, and NF-1 (28) and the family of CCAAT/enhancer-binding protein (C/EBP ␣, ␤, ␥, ␦, ⑀, and CHOP10) (29) . However, the possibility that member(s) of this large family of proteins may interact with the CCAAT element in PI promoter and affect its basal activity remains speculative. In addition, the TATA-like elements and presumably their associated proteins may exert constitutively down-regulatory influence(s) in promoter I function, conceivably through interaction with SF-1 or the preinitiation complex, whose formation should be presumably independent of the TATA boxes in this promoter. Therefore, the PRLR promoter I belongs to the class of TATA-less/non-initiator, GC box-less gene promoters.
Our studies have demonstrated that the SF-1 protein binds to its cognate regulatory element within the PI promoter domain and exerts a dominant effect on the activation of this promoter. In addition, a CCAAT element may have minor contribution to the basal promoter activity, and a TATA-like region may provide a constitutive inhibitory site for this promoter. These important functional gene structures are amenable to multifunctional regulation during the development of testicular Leydig cells from fetal to adult life and at the different stages of the ovarian cycle. ) were transiently infected with the adenovirus constructs containing the minimal promoter domain of PI(Ϫ700/Ϫ549)/LUC/Adv (wild type) or its SF-1 mutant adenovirus construct (SF1X). Promoterless (Basic) and SV40 promoter-driven (SV40) adenovirus constructs were also used for infection of both cell types. The promoter activities are indicated as percentages of the wildtype activity (100%). The data are expressed as mean Ϯ S.E. of three independent infections in quadruplicate.
